Clinical Trials Browser

Phase 2 × Pulmonary Neuroendocrine Tumor × 90 days × Clear all

NCT07357623 2026-01-22

Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors

Phase 2 Recruiting

Pulmonary Neuroendocrine Tumor